Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Revenue: 2020-2025

Historic Revenue for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $1.6 million.

  • Roivant Sciences' Revenue fell 64.89% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year decrease of 45.59%. This contributed to the annual value of $29.1 million for FY2025, which is 11.19% down from last year.
  • Per Roivant Sciences' latest filing, its Revenue stood at $1.6 million for Q3 2025, which was down 27.60% from $2.2 million recorded in Q2 2025.
  • Roivant Sciences' Revenue's 5-year high stood at $24.3 million during Q4 2021, with a 5-year trough of $1.6 million in Q3 2025.
  • In the last 3 years, Roivant Sciences' Revenue had a median value of $6.2 million in 2024 and averaged $8.3 million.
  • In the last 5 years, Roivant Sciences' Revenue soared by 957.22% in 2021 and then plummeted by 72.84% in 2025.
  • Over the past 5 years, Roivant Sciences' Revenue (Quarterly) stood at $24.3 million in 2021, then fell by 29.95% to $17.1 million in 2022, then dropped by 8.74% to $15.6 million in 2023, then slumped by 42.05% to $9.0 million in 2024, then tumbled by 64.89% to $1.6 million in 2025.
  • Its Revenue was $1.6 million in Q3 2025, compared to $2.2 million in Q2 2025 and $9.0 million in Q4 2024.